All rights reserved. This material may be freely reproduced for educational and not-for-profit purposes. No reproduction by or for commercial organisations, or for commercial purposes, is allowed without the express written permission of NICE.
NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.
Contents
Final
Developed by the National Institute for Health and Care Excellence
Disclaimer: Healthcare professionals are expected to take NICE clinical guidelines fully into account when exercising their clinical judgement. However, the guidance does not override the responsibility of healthcare professionals to make decisions appropriate to the circumstances of each patient, in consultation with the patient and/or their guardian or carer.
- NICE Clinical Guideline 144: Venous Thromboembolic Diseases: The Management of Venous Thromboembolic Diseases and the Role of Thrombophilia Testing
- Venous thromboembolic diseases: Evidence Update April 2014: A summary of selected new evidence relevant to NICE clinical guideline 144 'Venous thromboembolic diseases: the management of venous thromboembolic diseases and the role of thrombophilia testing' (2012)
- 2018 exceptional surveillance of venous thromboembolic diseases: diagnosis, management and thrombophilia testing (NICE guideline CG144)
- Surveillance report 2016 - Venous thromboembolic diseases (2012) NICE guideline CG144
- Addendum to Clinical Guideline 144, Venous thromboembolic diseases in adults: di...Addendum to Clinical Guideline 144, Venous thromboembolic diseases in adults: diagnosis, management and thrombophilia testing
Your browsing activity is empty.
Activity recording is turned off.
See more...